Enterprise setup guide

    Connect your SIP trunk or CCaaS

    Already have a phone system or contact-centre platform? You can bring your own SIP connection to VoiceBiota instead of using Twilio or Vapi. This guide explains what to prepare and what happens after you save.

    1. 1. Gather your trunk details

      Ask your carrier or contact-centre platform (CCaaS) for the SIP address calls should reach, plus a username and password created for VoiceBiota. A SIP address looks like sip:agent@trunk.example.com.

    2. 2. Enter them in Call setup

      In the Enterprise dashboard, open Call setup, choose BYO SIP / CCaaS, and fill in SIP URI, Username and Password. Only members of your organisation can see or change these details.

    3. 3. We confirm the connection with you

      Automatic checks run for Twilio and Vapi, but SIP trunks differ too much between carriers to test automatically. After you save, the setup shows "SIP config saved (manual verification required)". Our team then arranges a short test call with you before live traffic starts.

    What to ask your carrier

    • The SIP address (URI) or host name that should receive calls
    • Whether it uses a username and password, and a set created only for VoiceBiota
    • Whether it needs a fixed list of allowed addresses, so we can agree them together
    • Which audio formats (codecs) and encryption it supports
    • Who on your side can join a test call

    Good practice

    • Create a separate username and password for VoiceBiota, never reuse your administrator login.
    • Change the password if someone with access leaves, then update it in Call setup.
    • Tell callers about voice analysis in your own call greeting, as your local rules require.
    • Start with a small test group before sending all calls.

    Need help?

    Send us your carrier name and a contact for the test call, and we will take it from there.

    Research & Evaluation Use Only.

    ⚠️ Research & Evaluation Use Only: Not for Clinical Use. All voice biomarker values are directional research insights. Not intended for diagnosis or treatment. CE (MDR) certification currently underway. Rezpio is under CE certification for intended use in COPD and Asthma patient management and can currently only be used for research and evaluation purposes.